Saltigo Opens cGMP Plant; Eyes Accelerated Growth

Saltigo (Langenfeld, Germany), the wholly owned fine chemical subsidiary of Lanxess, has officially inaugurated a €10-million ($14.5 million), state-of-the-art cGMP custom manufacturing facility at Leverkusen and pledged to invest €50 million through 2009 to position the business for further growth. The four-module, multipurpose cGMP unit, dubbed O10, can produce more than 200 m.t./year of advanced pharmaceutical intermediates (API), registered intermediates, and starting compounds for the pharmaceutical industry. It adds about 25% to Saltigo’s...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers